Differences

This shows you the differences between two versions of the page.

--- home:symptoms:gastrointestinal:diarrhea [01.16.2020] – [Patient experiences] sallieq
+++ home:symptoms:gastrointestinal:diarrhea [09.14.2022] (current) – external edit 127.0.0.1
@@ Line 2: / Line 2: @@
-<note warning>Severe and recurrent diarrhea can lead to dehydration and is therefore life-threatening. Patients who experience constant diarrhea for two days or more should contact their physician and post on the [[http://marshallprotocool.com|Marshall Protocol site]].</note>
+<note warning>Severe and recurrent diarrhea can lead to dehydration and is therefore life-threatening. Patients who experience constant diarrhea for two days or more should contact their physician and post on the [[https://marshallprotocool.com|Marshall Protocol site]].</note>
@@ Line 17: / Line 17: @@
 Marshall Protocol (MP) patients who have routine diarrhea should be receptive to how even small amounts of light exposure can contribute to a flare in symptoms.
-Evolutionary biologist Paul Ewald [[http://bacteriality.com/2008/02/11/ewald/|has suggested]] that at least some cases of diarrhea endow pathogens with an evolutionary advantage, allowing them to persist and infect others.
+Evolutionary biologist Paul Ewald [[https://bacteriality.com/2008/02/11/ewald/|has suggested]] that at least some cases of diarrhea endow pathogens with an evolutionary advantage, allowing them to persist and infect others.
@@ Line 39: / Line 39: @@
 ===== Research =====
-Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pubmed>long:25023670}}))
+Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pmid>long:25023670}}))
-In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pubmed>long:25947920}}))
+In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pmid>long:25947920}}))
 ==== Probiotics ====
@@ Line 75: / Line 75: @@
 {{tag>symptoms gastrointestinal}}
+<nodisp>
 ===== Notes and comments =====
   * Legacy content
-    * http://www.marshallprotocol.com/forum32/8159.html f164
+    * https://www.marshallprotocol.com/forum32/8159.html f164
   *
@@ Line 91: / Line 92: @@
 From: Dody
 Date: 2009-11-29 19:35:24
-Reply: http://www.marshallprotocol.com/reply.php?topic_id=13340
+Reply: https://www.marshallprotocol.com/reply.php?topic_id=13340
@@ Line 163: / Line 164: @@
 </blockquote>
+</nodisp>

home/symptoms/gastrointestinal/diarrhea.txt · Last modified: 09.14.2022 by 127.0.0.1